i-SENS

아이센스 – i-SENS, Inc.

i-SENS was founded in 2000 and is headquartered in Seoul, South Korea.

Headquarters
Seoul
Founded
2000
Business Model
B2B

About

i-SENS, Inc. is a South Korean medical device company founded in 2000, headquartered in Seocho-gu, Seoul. The company researches, develops, and manufactures advanced biosensor-based diagnostic devices distributed worldwide using proprietary electrochemical technology. Its product range includes blood glucose monitoring systems (BGMS), continuous glucose monitoring systems (CGMS) such as the CareSens Air, glycated hemoglobin meters, blood electrolyte and gas analyzers, immunoassay protein analyzers (IVD systems), and veterinary diagnostics. i-SENS holds the No. 1 market share in Korea for blood glucose monitoring and has a global manufacturing capacity exceeding 1 billion strips per year with presence in more than 100 countries. The company has subsidiaries including i-SENS (Jiangsu) Co., Ltd. in China and i-SENS USA, Inc., and has been publicly listed on the Korean stock market. In 2023, i-SENS received a bronze medal from EcoVadis for its ESG supply chain practices.

Summary

i-SENS is a Biotech company based in Seoul, South Korea, founded in 2000.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

i-SENS on Indexed.vc
<a href="https://indexed.vc/companies/i-sens"><img src="https://indexed.vc/api/badge/company/i-sens" alt="i-SENS on Indexed.vc" width="260" height="76" /></a>